Galimedix Therapeutics, Inc. |

Galimedix Therapeutics, Inc.

Galimedix is a Phase 2 clinical-stage private biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases.
Founded by a seasoned and highly dedicated team of bio-entrepreneurs, pharmaceutical executives, and scientists, Galimedix’s groundbreaking small molecules administered orally or as eye drops offer the hope of
changing the course of disease where amyloid beta (Aβ) plays a role, such as in Alzheimer’s disease (AD), dry age-related macular degeneration (dAMD)/geographic atrophy (GA), and glaucoma (including normal tension glaucoma) – Galimedix’s current areas of focus.

Field of Activity	Current areas of focus are Alzheimer’s disease, dry age-related macular degeneration/geographic atrophy (GA), and glaucoma, including normal tension glaucoma (NTG).
Ownership Structure and Financing	Private, seeking additional investors for a crossover round as preparation for an US IPO.
Partners	Théa Open Innovation – development & commercialization of GAL-101 for dAMD, glaucoma & other ophthalmic indications in Europe, the Americas, the Middle East & Africa Seeking partners for GAL-101 – ophthalmology: Greater China, Asia/Pacific GAL-101 – Alzheimer’s Disease (AD): global
Technology	Stopping neurodegeneration at source – small molecules that block misfolded amyloid beta (Aβ) from forming toxic Aβ oligomers that lead to disease and help to remove existing oligomers
Products/Services	GAL-101 (eye drops) – Phase 2 – dAMD/GA (ongoing), glaucoma (planned) GAL-101 (oral) – Phase 1 completed – AD, dAMD/GA, glaucoma
Unique Selling Point	Blocks disease at source Potential new standard of care for all stages of the disease Partial regain of lost function Prevents/removes all toxic Aβ species Patient-friendly: oral, eye drops Sustained action per application

Contact

Alexander Gebauer, M.D., Ph.D. Co-founder, Executive Chairman

Address	3704 Calvend Lane Kensington, MD 20895 USA
Telephone/	+972 54 227 4827
E-Mail	info@galimedix.com
Web Address	www.galimedix.com/
Date of Incorporation/Number of Employees	2018/10

ARTIKEL ZU DIESEN SCHLAGWORTEN